BioNxt Solutions Inc. (OTCMKTS:BNXTF) Sees Significant Increase in Short Interest

BioNxt Solutions Inc. (OTCMKTS:BNXTF) was the recipient of a significant growth in short interest in January. As of January 30th, there was short interest totaling 2,018 shares, a growth of 101.8% from the January 15th total of 1,000 shares. Based on an average daily trading volume, of 4,774 shares, the short-interest ratio is currently 0.4 days. Currently, 0.0% of the shares of the stock are short sold. Currently, 0.0% of the shares of the stock are short sold. Based on an average daily trading volume, of 4,774 shares, the short-interest ratio is currently 0.4 days.

BioNxt Solutions Stock Performance

OTCMKTS BNXTF opened at $0.47 on Friday. The firm’s fifty day moving average price is $0.44 and its two-hundred day moving average price is $0.54. The stock has a market cap of $57.23 million, a PE ratio of -11.68 and a beta of 0.82. BioNxt Solutions has a fifty-two week low of $0.22 and a fifty-two week high of $0.80.

BioNxt Solutions (OTCMKTS:BNXTF) last released its quarterly earnings data on Friday, November 28th. The company reported ($0.01) earnings per share for the quarter. The company had revenue of $0.01 million during the quarter.

BioNxt Solutions Company Profile

BioNxt Solutions Inc (OTCMKTS:BNXTF) is a life sciences company specializing in advanced proteomics, metabolomics and bioinformatics solutions. The company’s platform combines state-of-the-art mass spectrometry and chromatography workflows with cloud-based data analysis tools, enabling high-throughput characterization of proteins, metabolites and other biomolecules for research and development purposes.

BioNxt Solutions offers contract research services to clients in the pharmaceutical, biotechnology and academic sectors, providing end-to-end support from sample preparation through to data interpretation.